Lisata Therapeutics agrees to Kuva Labs buyout at $4 per share

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop